Title : CYP2B6 non-coding variation associated with smoking cessation is also associated with differences in allelic expression, splicing, and nicotine metabolism independent of common amino-acid changes.

Pub. Date : 2013

PMID : 24260284






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CYP2B6 non-coding variation associated with smoking cessation is also associated with differences in allelic expression, splicing, and nicotine metabolism independent of common amino-acid changes. Nicotine cytochrome P450 family 2 subfamily B member 6 Homo sapiens
2 The Cytochrome P450 2B6 (CYP2B6) enzyme makes a small contribution to hepatic nicotine metabolism relative to CYP2A6, but CYP2B6 is the primary enzyme responsible for metabolism of the smoking cessation drug bupropion. Nicotine cytochrome P450 family 2 subfamily B member 6 Homo sapiens
3 The Cytochrome P450 2B6 (CYP2B6) enzyme makes a small contribution to hepatic nicotine metabolism relative to CYP2A6, but CYP2B6 is the primary enzyme responsible for metabolism of the smoking cessation drug bupropion. Nicotine cytochrome P450 family 2 subfamily B member 6 Homo sapiens
4 Using CYP2A6 genotype as a covariate, we find that a non-coding polymorphism in CYP2B6 previously associated with smoking cessation (rs8109525) is also significantly associated with nicotine metabolism. Nicotine cytochrome P450 family 2 subfamily B member 6 Homo sapiens